Cargando…

Marine Actinomycetes, New Sources of Biotechnological Products

The Actinomycetales order is one of great genetic and functional diversity, including diversity in the production of secondary metabolites which have uses in medical, environmental rehabilitation, and industrial applications. Secondary metabolites produced by actinomycete species are an abundant sou...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagannathan, Sveta V., Manemann, Erika M., Rowe, Sarah E., Callender, Maiya C., Soto, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304352/
https://www.ncbi.nlm.nih.gov/pubmed/34201951
http://dx.doi.org/10.3390/md19070365
_version_ 1783727314111037440
author Jagannathan, Sveta V.
Manemann, Erika M.
Rowe, Sarah E.
Callender, Maiya C.
Soto, William
author_facet Jagannathan, Sveta V.
Manemann, Erika M.
Rowe, Sarah E.
Callender, Maiya C.
Soto, William
author_sort Jagannathan, Sveta V.
collection PubMed
description The Actinomycetales order is one of great genetic and functional diversity, including diversity in the production of secondary metabolites which have uses in medical, environmental rehabilitation, and industrial applications. Secondary metabolites produced by actinomycete species are an abundant source of antibiotics, antitumor agents, anthelmintics, and antifungals. These actinomycete-derived medicines are in circulation as current treatments, but actinomycetes are also being explored as potential sources of new compounds to combat multidrug resistance in pathogenic bacteria. Actinomycetes as a potential to solve environmental concerns is another area of recent investigation, particularly their utility in the bioremediation of pesticides, toxic metals, radioactive wastes, and biofouling. Other applications include biofuels, detergents, and food preservatives/additives. Exploring other unique properties of actinomycetes will allow for a deeper understanding of this interesting taxonomic group. Combined with genetic engineering, microbial experimental evolution, and other enhancement techniques, it is reasonable to assume that the use of marine actinomycetes will continue to increase. Novel products will begin to be developed for diverse applied research purposes, including zymology and enology. This paper outlines the current knowledge of actinomycete usage in applied research, focusing on marine isolates and providing direction for future research.
format Online
Article
Text
id pubmed-8304352
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83043522021-07-25 Marine Actinomycetes, New Sources of Biotechnological Products Jagannathan, Sveta V. Manemann, Erika M. Rowe, Sarah E. Callender, Maiya C. Soto, William Mar Drugs Review The Actinomycetales order is one of great genetic and functional diversity, including diversity in the production of secondary metabolites which have uses in medical, environmental rehabilitation, and industrial applications. Secondary metabolites produced by actinomycete species are an abundant source of antibiotics, antitumor agents, anthelmintics, and antifungals. These actinomycete-derived medicines are in circulation as current treatments, but actinomycetes are also being explored as potential sources of new compounds to combat multidrug resistance in pathogenic bacteria. Actinomycetes as a potential to solve environmental concerns is another area of recent investigation, particularly their utility in the bioremediation of pesticides, toxic metals, radioactive wastes, and biofouling. Other applications include biofuels, detergents, and food preservatives/additives. Exploring other unique properties of actinomycetes will allow for a deeper understanding of this interesting taxonomic group. Combined with genetic engineering, microbial experimental evolution, and other enhancement techniques, it is reasonable to assume that the use of marine actinomycetes will continue to increase. Novel products will begin to be developed for diverse applied research purposes, including zymology and enology. This paper outlines the current knowledge of actinomycete usage in applied research, focusing on marine isolates and providing direction for future research. MDPI 2021-06-25 /pmc/articles/PMC8304352/ /pubmed/34201951 http://dx.doi.org/10.3390/md19070365 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jagannathan, Sveta V.
Manemann, Erika M.
Rowe, Sarah E.
Callender, Maiya C.
Soto, William
Marine Actinomycetes, New Sources of Biotechnological Products
title Marine Actinomycetes, New Sources of Biotechnological Products
title_full Marine Actinomycetes, New Sources of Biotechnological Products
title_fullStr Marine Actinomycetes, New Sources of Biotechnological Products
title_full_unstemmed Marine Actinomycetes, New Sources of Biotechnological Products
title_short Marine Actinomycetes, New Sources of Biotechnological Products
title_sort marine actinomycetes, new sources of biotechnological products
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304352/
https://www.ncbi.nlm.nih.gov/pubmed/34201951
http://dx.doi.org/10.3390/md19070365
work_keys_str_mv AT jagannathansvetav marineactinomycetesnewsourcesofbiotechnologicalproducts
AT manemannerikam marineactinomycetesnewsourcesofbiotechnologicalproducts
AT rowesarahe marineactinomycetesnewsourcesofbiotechnologicalproducts
AT callendermaiyac marineactinomycetesnewsourcesofbiotechnologicalproducts
AT sotowilliam marineactinomycetesnewsourcesofbiotechnologicalproducts